Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.

FOR IMMEDIATE RELEASE Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities Paris, France —27, June, 2025— Orphalan ...

Alcohol-associated liver disease mortality doubled from 1999 to 2022, with pronounced increases among women, younger adults, and American Indian and Alaska Native populations, according to study ...

One of the most common causes of liver disease besides alcohol is non-alcoholic fatty liver disease (NAFLD). This happens ...

Once considered a niche concern, it is now a growing global epidemic affecting more than one in four adults worldwide.

Alcohol-related liver disease progresses in stages. At first, fat begins to accumulate in the liver (fatty liver), often without any noticeable symptoms and is reversible if drinking stops.

Wilson Disease Pathogenesis and Clinical Considerations in Diagnosis and Treatment Richard Rosencrantz, M.D.; Michael Schilsky, M.D. Disclosures Semin Liver Dis. 2011;31 (3):245-259.

Telomir Pharmaceuticals, Inc, a preclinical-stage biotechnology company focused on reversing biological aging and degenerative diseases, announced compelling new preclinical data demonstrating that ...

When the liver is damaged, bilirubin builds up in the bloodstream and causes the skin and the whites of the eyes to turn yellow. This yellow color is often first seen on the face, hands, and feet.

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is among the 10 Best Growth Stocks Under $100 to Buy Now. On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) revealed that its leading product, ...

Wilson’s disease is an inherited condition that causes copper to collect in your body. Wilson’s disease is autosomal recessive. This means you must have two copies of the gene to develop the condition ...

And in Wilson's disease, we saw a reversal of neurological, liver and kidney damage. These results point to the broad therapeutic potential of Telomir-1 across diseases driven by cellular ...